THR0921, a novel peroxisome proliferator-activated receptor gamma agonist, reduces the severity of collagen-induced arthritis

THR0921 is a novel peroxisome proliferator-activated receptor gamma (PPARγ) agonist with potent anti-diabetic properties. Because of the proposed role of PPARγ in inflammation, we investigated the potential of orally active THR0921 to inhibit the pathogenesis of collagen-induced arthritis (CIA). CIA...

Descripción completa

Detalles Bibliográficos
Autores principales: Tomita, Tetsuya, Kakiuchi, Yoshimi, Tsao, Philip S
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1526548/
https://www.ncbi.nlm.nih.gov/pubmed/16356194
http://dx.doi.org/10.1186/ar1856

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1526548/
https://www.ncbi.nlm.nih.gov/pubmed/16356194
http://dx.doi.org/10.1186/ar1856

Ejemplares similares